Cellebrite DI (CLBT) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Cellebrite DI (US:CLBT), trading at 14.57. In 2025, Cellebrite DI generated $475.68 Million in revenue and $155.73 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Cellebrite DI is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: 14.57
- Recent Revenue (2025): $475.68 Million
- Free Cash Flow (2025): $155.73 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.